Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients.
BACKGROUND
Although meta-analyses of randomized trials have shown that selective digestive decontamination (SDD) prevents nosocomial pneumonia in critically ill patients, the influence of trial quality on the effectiveness of SDD has not been rigorously evaluated.


OBJECTIVE
To assess the methodological quality of individual studies of SDD and its relation to the reported effects on pneumonia and mortality.


METHODS
Thirty-two studies were identified in a MEDLINE and reference list search and their methodological quality was assessed using a scoring system (range, 0-13 points) based on allocation and concealment, patient selection, patient characteristics, blinding of the intervention, and the definition of pneumonia.


METHODS
Methodological quality of the primary trials and its effect on the relative risk reductions (RRRs) of SDD on pneumonia and mortality.


RESULTS
The mean (SD) methodological quality score was 7.8 (2.9) (range, 1-11). The RRRs ranged from -0.1 to 1.0 for pneumonia and from -0.1 to 0.6 for mortality. The methodological quality score was associated with the RRR for pneumonia so that for each quality-point added, the RRR decreased by 5.8% (95% confidence interval, 2.4%-9.3%). No association between trial quality and the impact of SDD was found on mortality. Of the individual trial quality characteristics, patient selection, allocation of intervention, and blinding most strongly influenced the treatment effect.


CONCLUSIONS
The inverse relationship between methodological quality score and the benefit of SDD on the incidence of pneumonia may have resulted in overly optimistic estimates of SDD in prior meta-analyses. This emphasizes the importance of rigorous trial design in evaluating preventive interventions in the intensive care unit.
van Nieuwenhoven
C A
CA
Department of Internal Medicine, Division of Infectious Diseases and AIDS, University Hospital, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands. m.bonten@wxs.nl
Buskens
E
E
van Tiel
F H
FH
Bonten
M J
MJ
D019072:Antibiotic Prophylaxis; D015982:Bias; D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D003422:Critical Care; D016638:Critical Illness; D003428:Cross Infection / Q000517:prevention & control*; D003627:Data Interpretation, Statistical; D003666:Decontamination; D004064:Digestive System / Q000382:microbiology*; D017052:Hospital Mortality; D006801:Humans; D017053:Infection Control / Q000379:methods*; D007362:Intensive Care Units; D015201:Meta-Analysis as Topic; D011014:Pneumonia / Q000517:prevention & control*; D011786:Quality Control; D012107:Research Design